CN101568639B - 用于病毒生产的培养基补充物 - Google Patents
用于病毒生产的培养基补充物 Download PDFInfo
- Publication number
- CN101568639B CN101568639B CN2007800460588A CN200780046058A CN101568639B CN 101568639 B CN101568639 B CN 101568639B CN 2007800460588 A CN2007800460588 A CN 2007800460588A CN 200780046058 A CN200780046058 A CN 200780046058A CN 101568639 B CN101568639 B CN 101568639B
- Authority
- CN
- China
- Prior art keywords
- cell
- virus
- amphotericin
- type
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
添加两性霉素B[+/-] | 滴度[TCID50/ml] |
+ | 2.0E+04 |
- | <1.0E+01 |
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06450142.2 | 2006-10-12 | ||
EP06450142A EP1911836A1 (en) | 2006-10-12 | 2006-10-12 | Medium supplement for virus production |
PCT/EP2007/060804 WO2008043805A1 (en) | 2006-10-12 | 2007-10-11 | Medium supplement for virus production |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310051392XA Division CN103232976A (zh) | 2006-10-12 | 2007-10-11 | 用于病毒生产的培养基补充物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101568639A CN101568639A (zh) | 2009-10-28 |
CN101568639B true CN101568639B (zh) | 2013-03-27 |
Family
ID=37834203
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800460588A Active CN101568639B (zh) | 2006-10-12 | 2007-10-11 | 用于病毒生产的培养基补充物 |
CN201310051392XA Pending CN103232976A (zh) | 2006-10-12 | 2007-10-11 | 用于病毒生产的培养基补充物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310051392XA Pending CN103232976A (zh) | 2006-10-12 | 2007-10-11 | 用于病毒生产的培养基补充物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8288145B2 (zh) |
EP (2) | EP1911836A1 (zh) |
JP (1) | JP5298377B2 (zh) |
KR (1) | KR101485441B1 (zh) |
CN (2) | CN101568639B (zh) |
AU (1) | AU2007306324C1 (zh) |
CA (1) | CA2665603C (zh) |
EA (1) | EA018438B1 (zh) |
ES (1) | ES2403098T3 (zh) |
PL (1) | PL2087104T3 (zh) |
WO (1) | WO2008043805A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA024262B1 (ru) * | 2008-11-25 | 2016-09-30 | Нанотерапьютикс Инк. | СПОСОБ ПОЛУЧЕНИЯ ВЫСОКОИНФЕКЦИОННОГО ВИРУСА ГРИППА, СТАБИЛЬНОГО ПРИ НИЗКИХ pH |
WO2011009864A1 (en) | 2009-07-22 | 2011-01-27 | Avir Green Hills Biotechnology Research Development Trade Ag | Novel influenza virus |
AR080972A1 (es) | 2010-04-28 | 2012-05-23 | Abbott Biologicals Bv | Produccion de componentes virales |
CN103223162B (zh) * | 2013-04-03 | 2014-07-30 | 华南农业大学 | 一株h3n2犬流感病毒株cgd1的应用 |
WO2015032043A1 (zh) * | 2013-09-04 | 2015-03-12 | 华为技术有限公司 | 传输数据的方法、装置和系统 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070239A1 (en) * | 2000-03-22 | 2001-09-27 | Thomas Jefferson University | Use of azithromycin for infections with leishmania |
WO2002024876A2 (en) * | 2000-09-25 | 2002-03-28 | Polymun Scientific Immunbiologische Forschung Gmbh | Live influenza vaccine and method of manufacture |
EP1350510A1 (en) * | 2002-03-07 | 2003-10-08 | The Kitasato Institute | Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus |
WO2004110473A1 (en) * | 2003-05-27 | 2004-12-23 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783411A (en) * | 1984-10-22 | 1988-11-08 | Janis Gabliks | Influenza-A virus vaccine from fish cell cultures |
ZA953703B (en) * | 1994-05-10 | 1996-01-10 | American Home Prod | Modified live BRSV vaccine |
US5824536A (en) | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
ATE384126T1 (de) | 1998-06-12 | 2008-02-15 | Sinai School Medicine | Interferon induzierende genetisch veränderte attenuierte viren |
DK1086207T3 (da) | 1998-06-12 | 2007-05-29 | Sinai School Medicine | Hidtil ukendte fremgangsmåder og inteferon-deficiente substrater til opformering af vira |
TWI295688B (en) * | 2000-06-07 | 2008-04-11 | A method for inhibition of enterovirus and/or influenza virus reproduction by allophycocyanin in vitro | |
US20030018074A1 (en) * | 2001-07-06 | 2003-01-23 | Robert Kleiman | Antiviral composition and treatment method |
US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
DE102007019191B4 (de) | 2006-07-10 | 2016-09-22 | Gea Westfaliasurge Gmbh | Zitzengummi mit stoßabsorbierenden Eigenschaften |
-
2006
- 2006-10-12 EP EP06450142A patent/EP1911836A1/en not_active Withdrawn
-
2007
- 2007-10-11 US US12/444,248 patent/US8288145B2/en active Active
- 2007-10-11 CA CA2665603A patent/CA2665603C/en active Active
- 2007-10-11 KR KR1020097007994A patent/KR101485441B1/ko active IP Right Grant
- 2007-10-11 ES ES07821171T patent/ES2403098T3/es active Active
- 2007-10-11 WO PCT/EP2007/060804 patent/WO2008043805A1/en active Application Filing
- 2007-10-11 PL PL07821171T patent/PL2087104T3/pl unknown
- 2007-10-11 EA EA200900526A patent/EA018438B1/ru not_active IP Right Cessation
- 2007-10-11 JP JP2009531844A patent/JP5298377B2/ja active Active
- 2007-10-11 CN CN2007800460588A patent/CN101568639B/zh active Active
- 2007-10-11 AU AU2007306324A patent/AU2007306324C1/en not_active Ceased
- 2007-10-11 EP EP07821171A patent/EP2087104B1/en active Active
- 2007-10-11 CN CN201310051392XA patent/CN103232976A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070239A1 (en) * | 2000-03-22 | 2001-09-27 | Thomas Jefferson University | Use of azithromycin for infections with leishmania |
WO2002024876A2 (en) * | 2000-09-25 | 2002-03-28 | Polymun Scientific Immunbiologische Forschung Gmbh | Live influenza vaccine and method of manufacture |
EP1350510A1 (en) * | 2002-03-07 | 2003-10-08 | The Kitasato Institute | Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus |
WO2004110473A1 (en) * | 2003-05-27 | 2004-12-23 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
Non-Patent Citations (1)
Title |
---|
Christian Kittel et al..Rescue of influenza virus expressing GFP from the NS1 reading frame.《Virology》.2004,第324卷(第1期),67-73. * |
Also Published As
Publication number | Publication date |
---|---|
CN101568639A (zh) | 2009-10-28 |
PL2087104T3 (pl) | 2014-01-31 |
JP2011502466A (ja) | 2011-01-27 |
JP5298377B2 (ja) | 2013-09-25 |
US8288145B2 (en) | 2012-10-16 |
EP2087104A1 (en) | 2009-08-12 |
EA200900526A1 (ru) | 2009-12-30 |
EP2087104B1 (en) | 2013-01-23 |
CA2665603A1 (en) | 2008-04-17 |
AU2007306324C1 (en) | 2013-11-07 |
AU2007306324A1 (en) | 2008-04-17 |
AU2007306324B2 (en) | 2013-07-18 |
KR20090064584A (ko) | 2009-06-19 |
CA2665603C (en) | 2016-10-04 |
KR101485441B1 (ko) | 2015-01-26 |
EA018438B1 (ru) | 2013-08-30 |
US20100003221A1 (en) | 2010-01-07 |
EP1911836A1 (en) | 2008-04-16 |
ES2403098T3 (es) | 2013-05-14 |
CN103232976A (zh) | 2013-08-07 |
WO2008043805A1 (en) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8691238B2 (en) | High growth reassortant influenza A virus | |
KR20070100891A (ko) | 인플루엔자 백신 조성물의 제조 방법 | |
CN101568639B (zh) | 用于病毒生产的培养基补充物 | |
Schultz-Cherry et al. | Induction of apoptosis by influenza virus | |
US20140377308A1 (en) | METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES | |
RU2529772C1 (ru) | Холодоадаптированный штамм вируса гриппа в-в/виктория/2/63/87, предназначенный в качестве штамма-донора аттенуации для получения реассортантов холодоадаптированных штаммов для живой гриппозной вакцины | |
US20040142450A1 (en) | Lung epithelial cell line for propagating viruses | |
WO2002089586A1 (en) | Lung epithelial cell line for propagating viruses | |
KR101855006B1 (ko) | 생산능이 향상된 재조합 조류 인플루엔자 바이러스 및 이를 포함하는 백신 조성물 | |
KR102098585B1 (ko) | 교차 면역원성을 갖는 h2 아형 인플루엔자 바이러스 및 이를 포함하는 백신 | |
US20220241397A1 (en) | Influenza virus backbone | |
US20230310578A1 (en) | Method for adapting influenza viruses to vero cells | |
AU2013204852A9 (en) | Medium supplement for virus production | |
CN117946982A (zh) | H1n1流感病毒冷适应疫苗骨架毒株cv1-pr8及其构建方法和应用 | |
US8834892B2 (en) | Method of preparing live viral vaccines by genetic engineering of viral genome | |
CN117946981A (zh) | H1n1流感病毒冷适应疫苗骨架毒株cv2-pr8及其构建方法和应用 | |
Stockton et al. | The influenza virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BAKST HELTH CO., LTD. Free format text: FORMER OWNER: AVIR GREEN HILLS BIOTECHNOLOGY Effective date: 20130626 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130626 Address after: Swiss Aupu Patentee after: BAXTER HEALTHCARE S.A. Address before: Austria Vienna Patentee before: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161010 Address after: American Florida Patentee after: nanomedicine Address before: Swiss Aupu Patentee before: Baxalta LLC Effective date of registration: 20161010 Address after: Swiss Aupu Patentee after: Baxalta LLC Address before: Swiss Aupu Patentee before: BAXTER HEALTHCARE S.A. |